Related Experiment Video
Updated: Jan 19, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Graphdiyne-Based One-Step DNA Fluorescent Sensing Platform for the Detection of Mycobacterium tuberculosis and Its
Fan Chang1, Lijun Huang1, Chaozhong Guo2
1Central Laboratory of Yongchuan Hospital , Chongqing Medical University , Chongqing 402160 , China.
Abstract:
The accurate and early detection of Mycobacterium tuberculosis (Mtb) is of great significance for the clinical diagnosis and treatment of tuberculosis. In this work, we report a facile method for the controllable synthesis of a novel few-layered two-dimensional graphdiyne nanosheet (GDY NS) with a thickness of only ∼0.9 nm via an electrochemical lithium-intercalation strategy, which possesses a prominent fluorescence quenching effect. The few-layered GDY NS with its strong adsorptivity for single-stranded DNA is first proposed as a new fluorescent sensing platform for the real-time detection of DNA with excellent specificity, multiplicity, and superhigh sensitivity (limit of detection as low as 25 pM). This sensing platform can be further applied for the Mtb detection from clinical samples and the identification of drug-resistant mutants with a low background and a high signal-to-noise ratio. Herein, we provide a potential basis for the clinical development of rapid, sensitive, and accurate substitutes for the molecular diagnosis of Mtb and its drug-resistant genes.
Related Concept Videos
07:35Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
10:06Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
05:14An Assay to Evaluate Drug Efficacy against a Mycobacterium tuberculosis Infection Model
12:39Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

